Immunohistochemical staining for transcription factor MafB in alveolar macrophages is correlated with spirometric measures of airflow limitation in smokers

Respirology

Volumn 16, Issue 1, 2011, Pages 124-130

  Sato, Michiko ^a   Shibata, Yoko ^a   Kimura, Tomomi ^a   Yamauchi, Keiko ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Kishi, Hiroyuki ^a   Oizumi, Hiroyuki ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Alveolar macrophage; Chronic obstructive pulmonary disease; MafB; Smoker

Indexed keywords

CIGARETTE SMOKE; TRANSCRIPTION FACTOR MAFB;

AGED; AIRFLOW; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATION ANALYSIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; LUNG RESECTION; LUNG TUMOR; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SMOKING HABIT; SPIROMETRY; UPREGULATION;

AGED; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MACROPHAGES, ALVEOLAR; MAFB TRANSCRIPTION FACTOR; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY;

EID: 79952259531     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01886.x     Document Type: Article

References (26)

1. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-55. (Pubitemid 47403272)
2. Lopez AD, Shibuya K, Rao C et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27: 397-412. (Pubitemid 43180921)
3. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 2003; 22: 672-88. (Pubitemid 37258549)
4. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: S29-32.
5. Shapiro SD. COPD unwound. N. Engl. J. Med. 2005; 352: 2016-19. (Pubitemid 40638374)
6. Kelly LM, Englmeier U, Lafon I et al. MafB is an inducer of monocytic differentiation. EMBO J. 2000; 19: 1987-97. (Pubitemid 30237574)
7. Kataoka K, Fujiwara KT, Noda M et al. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol. Cell. Biol. 1994; 14: 7581-91. (Pubitemid 24326424)
8. Sieweke MH, Tekotte H, Frampton J et al. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 1996; 85: 49-60. (Pubitemid 26116806)
9. Hanamura I, Iida S, Akano Y et al. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations. Jpn. J. Cancer Res. 2001; 92: 638-44. (Pubitemid 32633466)
10. van Stralen E, van de Wetering M, Agnelli L et al. Identification of primary MAFB target genes in multiple myeloma. Exp. Hematol. 2009; 37: 78-86.
11. Shaykhiev R, Krause A, Salit J et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 2009; 183: 2867-83.
12. Machiya J, Shibata Y, Yamauchi K et al. Enhanced expression of MafB inhibits macrophage apoptosis induced by cigarette smoke exposure. Am. J. Respir. Cell Mol. Biol. 2007; 36: 418-26. (Pubitemid 46622999)
13. Flood-Page P, Menzies-Gow A, Phipps S et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial sub-epithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 2003; 112: 1029-36. (Pubitemid 38056318)
14. Forster C, Waschke J, Burek M et al. Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J. Physiol. 2006; 573: 413-25. (Pubitemid 43871056)
15. Kokolakis G, Panagis L, Stathopoulos E et al. Fromthe protein to the graph: how to quantify immunohistochemistry staining of the skin using digital imaging. J. Immunol. Methods 2008; 331: 140-6.
16. Sompuram SR, Kodela V, Zhang K et al. A novel quality control slide for quantitative immunohistochemistry testing. J. Histochem. Cytochem. 2002; 50: 1425-34.
17. Tolivia J, Navarro A, del Valle E et al. Application of Photoshop and Scion Image analysis to quantification of signals in histochemistry, immunocytochemistry and hybridocytochemistry. Anal. Quant. Cytol. Histol. 2006; 28: 43-53. (Pubitemid 43334519)
18. Beckles MA, Spiro SG, Colice GL et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003; 123: 105S-14S.
19. Sin DD, Man SF, Marciniuk DD et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008; 177: 1207-14. (Pubitemid 351860929)
20. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797-9. (Pubitemid 47320803)
21. Ancuta P, Liu KY, Misra V et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics 2009; 10: 403.
22. Ancuta P, Rao R, Moses A et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 2003; 197: 1701-7. (Pubitemid 36745345)
23. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82. (Pubitemid 36859902)
24. Umehara H, Bloom ET, Okazaki T et al. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 34-40. (Pubitemid 38082409)
25. Aziz A, Vanhille L, Mohideen P et al. Development of macrophages with altered actin organization in the absence of MafB. Mol. Cell. Biol. 2006; 26: 6808-18. (Pubitemid 44387631)
26. Moriguchi T, Hamada M, Morito N et al. MafB is essential for renal development and F4/80 expression in macrophages. Mol. Cell. Biol. 2006; 26: 5715-27. (Pubitemid 44134328)